Showing items 601–700
Compositions and methods for modulating ghrelin-mediated conditions
Grant US-8309530-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNAi
Grant US-8309704-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
Grant US-8304530-B2
United States of America
Compositions and their uses directed to acetyl-CoA carboxylases
Grant US-8299041-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-8299039-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Application EP-2514758-A1
European Patent Office
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT…
Grant EP-1458741-B1
European Patent Office
Combination therapy for the treatment of cancer
Grant US-8268797-B2
United States of America
Modulation of glucose-6-phosphatase translocase expression
Grant US-8258114-B2
United States of America
Gene expression inhibition; connective tissue growth factor modulators; nucleosides…
Grant US-8258105-B2
United States of America
Modulation of diacylglycerol acyltransferase 2 expression
Grant US-8258289-B2
United States of America
Triggered RNAi
Grant US-8241854-B2
United States of America
siRNA useful to supress expression of EIF-5A1
Grant US-8242256-B2
United States of America
Vascular therapeutics
Grant US-8242090-B2
United States of America
Compositions and methods for silencing apolipoprotein B
Application US-8236943-B2
United States of America
Modulation of forkhead box O1A expression
Grant US-8227593-B2
United States of America
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods…
Application EP-2471953-A1
European Patent Office
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods…
Application EP-2471952-A1
European Patent Office
Compositions and their uses directed to PTPRU
Grant US-8202981-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8202980-B2
United States of America
Compositions and their uses directed to HBXIP
Grant US-8198253-B2
United States of America
Modified siRNA molecules and uses thereof
Grant US-8188263-B2
United States of America
Compounds and methods for modulating expression of GCGR
Grant US-8188059-B2
United States of America
Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and…
Application US-20120129910-A1
United States of America
Antisense oligonucleotide modulation of STAT3 expression
Grant US-8183363-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8183362-B2
United States of America
Compositions and methods for topical delivery of oligonucleotides
Grant US-8168600-B2
United States of America
Method for making a 21 nucleotide double stranded RNA chemically linked at one end
Grant US-8168776-B2
United States of America
Reduction of graft-versus-host disease by modulation of SHIP activity
Grant US-8163710-B2
United States of America
Compositions and their uses directed to PTPR alpha
Grant US-8158598-B2
United States of America
Modulation of diacylglycerol acyltransferase 1 expression
Grant US-8158597-B2
United States of America
RNAi modulation of RSV and therapeutic uses thereof
Grant US-8158773-B2
United States of America
Composition and methods for the pulmonary delivery of nucleic acids
Application US-8153602-B1
United States of America
Compositions and their uses directed to IL-4R alpha
Application US-8153603-B2
United States of America
Compounds and methods for modulating expression of PCSK9
Grant US-8143230-B2
United States of America
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses…
Application EP-2431483-A1
European Patent Office
Modulation of apolipoprotein (A) expression
Grant US-8138328-B2
United States of America
Hybridization chain reaction amplification for in situ imaging
Grant US-8124751-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8119608-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8114981-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8114851-B2
United States of America
Compositions and methods for the modulation of JNK proteins
Grant US-8101585-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8101584-B2
United States of America
Method and medicament for inhibiting the expression of a given gene
Grant US-8101742-B2
United States of America
Modulation of transthyretin expression
Grant US-8101743-B2
United States of America
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods…
Application EP-2405023-A2
European Patent Office
Methods for treating hypercholesterolemia
Grant US-8093222-B2
United States of America
Functional and hyperfunctional siRNA
Grant US-8090542-B2
United States of America
Modulation of SGLT2 expression
Grant US-8084436-B2
United States of America
Methods for treating hypercholesterolemia
Grant US-8084437-B2
United States of America
Methods and compositions for the specific inhibition of gene expression by double-stranded…
Grant US-8084599-B2
United States of America
Compositions and methods for treatment of pouchitis
Grant US-8084432-B2
United States of America
RNAI BASED SELECTION SYSTEM
Application US-20110311985-A1
United States of America
Compositions and their uses directed to hepcidin
Grant US-8076306-B2
United States of America
SIRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF…
Application WO-2011148193-A1
World Intellectual Property Organisation (WIPO)
siRNA and their use in methods and compositions for the treatment and/or prevention of…
Application EP-2390327-A1
European Patent Office
Modulation of eIF4E-BP2 expression
Grant US-8067386-B2
United States of America
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods…
Application EP-2386658-A2
European Patent Office
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods…
Application EP-2386657-A2
European Patent Office
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods…
Application EP-2386656-A2
European Patent Office
Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods…
Application EP-2386659-A2
European Patent Office
Methods and compositions concerning siRNA's as mediators of RNA interference
Grant US-8058255-B2
United States of America
Cells expressing vitamin K epoxide reductase and use thereof
Application EP-2380985-A1
European Patent Office
MICRO-RNA SCAFFOLDS, NON-NATURALLY OCCURRING MICRO-RNAS, AND METHODS FOR OPTIMIZING NON-NAT…
Application EP-2155911-A4
European Patent Office
Antisense permeation enhancers
Grant US-8039444-B2
United States of America
Compositions and their uses directed to diacylglycerol acyltransferase 1
Grant US-8003620-B2
United States of America
Anti-myosin Va siRNA and skin depigmentation
Grant US-7999096-B2
United States of America
RNAi modulation of the BCR-ABL fusion gene and uses thereof
Grant US-7994307-B2
United States of America
Antisense modulation of p38 mitogen activated protein kinase expression
Grant US-7981868-B2
United States of America
Methods and compositions for the correlation of single nucleotide polymorphisms in the…
Application EP-2336360-A1
European Patent Office
Regulating expression of transient receptor potential channel genes
Grant US-7964573-B2
United States of America
Compositions and methods for topical delivery of oligonucleotides
Grant US-7964579-B2
United States of America
Compositions and methods for the modulation of the expression of B7 protein
Grant US-7960355-B2
United States of America
Antisense modulation of stearoyl-CoA desaturase expression
Grant US-7960358-B2
United States of America
Rna constructs
Application EP-2330203-A2
European Patent Office
Compositions and their uses directed to huntingtin
Application US-7951934-B2
United States of America
RNA interference agents for therapeutic use
Grant US-7951784-B2
United States of America
METHODS OF ENHANCING PLURIPOTENTCY
Application WO-2011062559-A1
World Intellectual Property Organisation (WIPO)
RNA interference for the treatment of gain-of-function disorders
Grant US-7947658-B2
United States of America
iRNA agents targeting VEGF
Grant US-7947659-B2
United States of America
Methods and compositions for enhancing the efficacy and specificity of RNAi
Application EP-2314692-A2
European Patent Office
Modulation of glucagon receptor expression
Grant US-7919476-B2
United States of America
IRNA agents targeting VEGF
Grant US-7919473-B2
United States of America
Antisense modulation of superoxide dismutase 1, soluble expression
Grant US-7902163-B2
United States of America
Oligonucleotide compositions and methods for the modulation of the expression of B7…
Grant US-7897582-B2
United States of America
an antisense compound that hybridizes with a nucleic acid molecule that expreses PTPRU …
Grant US-7897583-B2
United States of America
Allele-specific RNA interference
Grant US-7892793-B2
United States of America
Compositions and methods for inhibiting expression of anti-apoptotic genes
Grant US-7868160-B2
United States of America
RNAi modulation of TGF-beta and therapeutic uses thereof
Application US-7846908-B2
United States of America
Antisense modulation of BCL2-associated X protein expression
Grant US-7846730-B2
United States of America
Modulation of growth hormone receptor expression and insulin-like growth factor expression
Grant US-7846906-B2
United States of America
siRNA silencing of filovirus gene expression
Grant US-7838658-B2
United States of America
Compositions and methods for inhibiting expression of a target gene
Grant US-7829693-B2
United States of America
Oligonucleotide sequences for use in controlling diacylglycerol acyltransferase 2 a nd…
Grant US-7825235-B2
United States of America
Functional and hyperfunctional siRNA directed against Bcl-2
Grant US-7820809-B2
United States of America
COMPOSITION FOR DELIVERY OF GENETIC MATERIAL
Application WO-2010119256-A1
World Intellectual Property Organisation (WIPO)
Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
Grant US-7816336-B2
United States of America
Modulation of forkhead box O1A expression
Grant US-7807649-B2
United States of America
Modulation of eIF4E-BP2 expression
Grant US-7807652-B2
United States of America
Showing items 601–700